Temporal gene expression in equine corpora lutea based on serial biopsies in vivo.

The research paper explores a new biopsy procedure developed for repeated sampling of a single equine corpus luteum over an estrous cycle. The procedure, which was tested on mares, allowed researchers to study the changes in abundance of mRNA for certain genes involved in luteal formation, function, and regression. The study found that the biopsy procedure had no negative effect on luteal size or functionality, and made important observations on the level of mRNA encoding for several different proteins.

Biopsy Procedure and Data Collection

• The article discusses a new biopsy procedure used for repeated sampling of equine corpus luteum (CL). CL is a temporary endocrine structure in mammals and forms after ovulation has taken place. The procedure enabled researchers to continuously monitor the activity of the equine CL throughout an entire estrous cycle.
• The biopsies were carried out on various dates and were carried out on five mares with a normal estrous cycle and one mare with a retained CL. The method used was an ultrasound-guided transvaginal technique.
• Luteal size and functionality were measured by monitoring luteal area and serum concentrations of progesterone, a key hormone in the regulation of the estrous and menstrual female reproductive cycles.

Study Findings

• The biopsies allowed researchers to observe the abundance of mRNA for genes involved in luteal formation, function, and regression. This could help shed light on conditions related to these functions, and how the equine estrous cycle works at a biochemical level.
• The study found that the biopsy procedure did not have any adverse effect on the size or functionality of the luteal body. This means it could be used in future studies without the risk of negatively affecting the subject’s wellbeing.
• The levels of mRNA coding for several proteins were tracked, including Steroidogenic acute regulatory protein (StAR), 3β-hydroxysteroid dehydrogenase, Δ 5-Δ 4 isomerase (3β-HSD), cyclooxygenase-2 (cox-2), and caspase-3. The study found that mRNA levels for StAR and 3β-HSD declined between day 12 and 14, with no significant differentiation in the levels of the other proteins.